Casadevall N - Search Results

1

Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera.

Ugo V, Marzac C, Teyssandier I, Larbret F, Lécluse Y, Debili N, Vainchenker W, Casadevall N. Ugo V, et al. Among authors: casadevall n. Exp Hematol. 2004 Feb;32(2):179-87. doi: 10.1016/j.exphem.2003.11.003. Exp Hematol. 2004. PMID: 15102479 Free article.

2

The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera.

Dupont S, Massé A, James C, Teyssandier I, Lécluse Y, Larbret F, Ugo V, Saulnier P, Koscielny S, Le Couédic JP, Casadevall N, Vainchenker W, Delhommeau F. Dupont S, et al. Among authors: casadevall n. Blood. 2007 Aug 1;110(3):1013-21. doi: 10.1182/blood-2006-10-054940. Epub 2007 Mar 27. Blood. 2007. PMID: 17389763 Free article.

3

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.

James C, Ugo V, Le Couédic JP, Staerk J, Delhommeau F, Lacout C, Garçon L, Raslova H, Berger R, Bennaceur-Griscelli A, Villeval JL, Constantinescu SN, Casadevall N, Vainchenker W. James C, et al. Among authors: casadevall n. Nature. 2005 Apr 28;434(7037):1144-8. doi: 10.1038/nature03546. Nature. 2005. PMID: 15793561

4

Role of tyrosine kinases and phosphatases in polycythemia vera.

Zhao ZJ, Vainchenker W, Krantz SB, Casadevall N, Constantinescu SN. Zhao ZJ, et al. Among authors: casadevall n. Semin Hematol. 2005 Oct;42(4):221-9. doi: 10.1053/j.seminhematol.2005.05.019. Semin Hematol. 2005. PMID: 16210035 Review.

5

A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects.

James C, Ugo V, Casadevall N, Constantinescu SN, Vainchenker W. James C, et al. Among authors: casadevall n. Trends Mol Med. 2005 Dec;11(12):546-54. doi: 10.1016/j.molmed.2005.10.003. Epub 2005 Nov 3. Trends Mol Med. 2005. PMID: 16271512 Review.

6

Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis.

Delhommeau F, Dupont S, Tonetti C, Massé A, Godin I, Le Couedic JP, Debili N, Saulnier P, Casadevall N, Vainchenker W, Giraudier S. Delhommeau F, et al. Among authors: casadevall n. Blood. 2007 Jan 1;109(1):71-7. doi: 10.1182/blood-2006-03-007146. Epub 2006 Sep 5. Blood. 2007. PMID: 16954506 Free article.

7

Molecular aspects of myeloproliferative neoplasms.

Delhommeau F, Jeziorowska D, Marzac C, Casadevall N. Delhommeau F, et al. Among authors: casadevall n. Int J Hematol. 2010 Mar;91(2):165-73. doi: 10.1007/s12185-010-0530-z. Epub 2010 Feb 27. Int J Hematol. 2010. PMID: 20186505 Review.

8

Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors.

Giraudier S, Chagraoui H, Komura E, Barnache S, Blanchet B, LeCouedic JP, Smith DF, Larbret F, Taksin AL, Moreau-Gachelin F, Casadevall N, Tulliez M, Hulin A, Debili N, Vainchenker W. Giraudier S, et al. Among authors: casadevall n. Blood. 2002 Oct 15;100(8):2932-40. doi: 10.1182/blood-2002-02-0485. Blood. 2002. PMID: 12351405 Free article.

9

[Erythropoiesis and its regulation].

Casadevall N, Vainchenker W. Casadevall N, et al. Rev Prat. 1993 Jun 1;43(11):1335-40. Rev Prat. 1993. PMID: 8235379 Review. French.

10

Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies.

Le Couedic JP, Mitjavila MT, Villeval JL, Feger F, Gobert S, Mayeux P, Casadevall N, Vainchenker W. Le Couedic JP, et al. Among authors: casadevall n. Blood. 1996 Feb 15;87(4):1502-11. Blood. 1996. PMID: 8608241 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters